Yang Li, Ph.D.

Executive Officer at Surrozen

Capital raised by Surrozen

$76.4M+$76.4M latest round

1 Form D filing · first filed Mar 2025 · South San Francisco, CA

CURRENT ROLE: Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: 2021
30D INTEREST: 1 ↗

Career

1 company on file · founded 2021

SurrozenBiotech · South San Francisco, CAsince 2021

Executive Officer

Listed on Surrozen's Form D filings

Company filings

via EDGAR · Form D for Surrozen1

DateCompanyFormAmountRole on filing

Mar 26, 2025SurrozenForm D+$76.4M—

Form DMar 26, 2025 · Surrozen+$76.4Mnot a signer

Overview

Last filing Mar 26, 2025

Yang Li, Ph.D. is on file as Executive Officer at Surrozen in South San Francisco, CA. Surrozen has 1 Form D filing on record, $76.4M raised in total.

Teammates

Surrozen · 1

Charles O. WilliamsChief Financial Officer and COOSigner

Products

Surrozen · 1

SZN-1326Biologic drug

SZN-1326 is a Fzd5-targeted antibody specifically designed to treat moderate to severe ulcerative colitis by stimulating Wnt signaling in the intestinal epithelium, thereby promoting tissue repair and healing.